Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
566,339
-
Shares change
-
+89,753
-
Total reported value, excl. options
-
$72,490,373
-
Value change
-
+$11,117,093
-
Put/Call ratio
-
330%
-
Number of buys
-
27
-
Number of sells
-
-35
-
Price
-
$128.00
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q1 2020
97 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q1 2020.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 566,339 shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (65,004 shares), ROYAL BANK OF CANADA (64,542 shares), GOLDMAN SACHS GROUP INC (50,000 shares), MORGAN STANLEY (45,092 shares), UBS Group AG (44,359 shares), MURPHY CAPITAL MANAGEMENT INC (35,092 shares), MOGY JOEL R INVESTMENT COUNSEL INC (21,923 shares), LPL Financial LLC (17,624 shares), ENVESTNET ASSET MANAGEMENT INC (14,650 shares), and BOSTON RESEARCH & MANAGEMENT INC (14,443 shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.